Skip to main content
SpringerLink
Log in

Substance Use Disorders in Transplant Patients

  • Chapter
  • First Online:
Psychosocial Care of End-Stage Organ Disease and Transplant Patients

Abstract

Alcohol, tobacco, and other substance use disorders are common in the general population and have significant medical complications. These disorders may cause or contribute to end-organ failure and the need for organ transplant. Post-transplant survival may be negatively impacted by pre- and post-transplant tobacco, alcohol, and other substance use. There is currently no consensus regarding the evaluation of transplant candidates with tobacco, alcohol, and other substance use disorders. There are concerns that some of these patients may be at high risk for relapse to alcohol, tobacco, and substance use and nonadherence resulting in poor transplant outcomes, medical complications, and premature death. Many studies have been done, but have not produced clear results on methods of predicting relapse in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, et al. Epidemiology of DSM-5 alcohol use disorders: results from the national epidemiologic survey on alcohol and related conditions III. JAMA Psychiat. 2015;72:757–66.

    Article  CAS  Google Scholar 

  2. Centers for Disease Control. Cigarette Smoking in the United States. 2017. htttps://www.cdc.gov/tobacco/campaign/tips/resources/data/cigarette-smoking-in-united-states.html. Accessed 9 Oct 2017.

  3. Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, et al. Epidemiology of DSM-5 drug use disorder: results from the national epidemiologic survey on alcohol and related conditions III. JAMA Psychiat. 2016;73:39–47.

    Article  Google Scholar 

  4. National Institutes of Health. Health consequences of Drug Misuse. 2017. https://www.drugabuse.gov/publications/health-consequences-drug-misuse. Accessed 9 Oct 2017.

  5. American Society of Addiction Medicine. Opioid Addiction Disease Facts and Figures. 2016. https://www.asam.org/docs/default-source/advocacy/opioid-addiction-disease-facts-figures.pdf. Accessed 20 Jan 2018.

  6. Parker R, Armstrong MJ, Corbett C, Day EJ, Neuberger JM. Alcohol and substance use in solid-organ transplant recipients. Transplantation. 2013;96:1015–24.

    Article  CAS  PubMed  Google Scholar 

  7. DiMartini AF, Sotelo JL, Dew MA. Organ transplantation. In: Levenson JL, editor. Textbook of psychosomatic medicine. Washington, DC: American Psychiatric Publishing; 2011. p. 725–58.

    Google Scholar 

  8. Beresford TP, Lucey ML. Towards standardizing the alcohol evaluation of potential liver transplant recipients. Alcohol Alcohol. 2017;104:1–10. https://doi.org/10.1093/alcalc/agx.

    Article  Google Scholar 

  9. Starzl TE, Van Thiel D, Tzakis AG, Iwatsuki S, Todo S, Marsh JW, et.al. Orthotopic liver transplantation for alcoholic cirrhosis. JAMA 1988;260:2542-2544.

    Article  CAS  PubMed  Google Scholar 

  10. Kumar S, Stauber RE, Gavaler JS. Orthotopic liver transplantation for alcoholic liver disease. Hepatology. 1990;11:159–64.

    Article  CAS  PubMed  Google Scholar 

  11. Bird GLA, O'Grady JG, Harvey FAH, Caine RY, Williams R. Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse. BMJ. 1990;301:15–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Osorio RW, Ascher NL, Avery M, Bacchetti P, Roberts JP, Lake JR. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology. 1994;20:105–10.

    CAS  PubMed  Google Scholar 

  13. Dew MA, DiMartini AF, Steel J, De Vito DA, Myaskovsky L, Unruh M, Greenhouse J. Meta-analysis of the risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl. 2008;14:159–72.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Pageaux GP, Bismuth M, Perney P, Costes V, Jaber S, Possoz P, et al. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter? J Hepatol. 2003;38:629–34.

    Article  CAS  PubMed  Google Scholar 

  15. DiMartini AF, Crone C, Dew MA. Alcohol and substance abuse in liver transplant patients. Clin Liver Dis. 2011;15:727–51.

    Article  PubMed  Google Scholar 

  16. Testino G, Leone S. Alcohol and liver transplantation. Alcohol Alcohol. 2017;52:129.

    Article  Google Scholar 

  17. Rice JP, Eickhoff J, Agni R, Ghufran A, Brahmbhatt R, Lucey MR. Abusive drinking after liver transplantation is associated with allograft loss and advanced allograft fibrosis. Liver Transpl. 19 2013;19: 1377–1386.

    Article  PubMed  Google Scholar 

  18. Lucey MR. Liver transplantation for alcoholic liver disease. Nat Rev – Gastroent Hepatol. 2014;11:300–7.

    Article  Google Scholar 

  19. Lucey MR, Weinrieb RM. Alcohol and substance abuse. Semin Liver Dis. 2008;29:66–73.

    Article  Google Scholar 

  20. Corbett C, Armstrong MJ, Neuberger J. Tobacco smoking and solid organ transplantation. Transplantation. 2012;94:979–87.

    Article  PubMed  Google Scholar 

  21. Oliveira CP, Stefano JT, Alvares-da-Silva MR. Cardiovascular risk, atherosclerosis and metabolic syndrome after liver transplantation: a mini review. Expert Rev Gastroenterol Hepatol. 2013;7:361–4.

    Article  PubMed  CAS  Google Scholar 

  22. Ursic-Bedoya J, Donnadieu-Rigole H, Faure S, Pageaux G. Alcohol use and smoking after liver transplantation: complications and prevention. Best Pract Res Clin Gastroenterol. 2017;31:181–5.

    Article  PubMed  Google Scholar 

  23. Iruzubieta P, Crespo J, Fabrega E. Long-term survival after liver transplantation for alcoholic cirrhosis. World J Gastroenterol. 2013;19:9198–208.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Heinrich TW, Marcangelo M. Psychiatric issues in solid organ transplantation. Harvard Rev Psychiatry. 2009;17:398–406.

    Article  Google Scholar 

  25. Rodrigue JR, Hanto DW, Curry MP. The alcohol relapse risk assessment: a scoring system to predict the risk of relapse to any alcohol use after liver transplant. Prog Transplant. 2013;23:310–8.

    Article  PubMed  Google Scholar 

  26. Marroni CA. Management of alcohol recurrence before and after liver transplantation. Clin Res Hepatol Gastroenterol. 2015;39:S109–14.

    Article  CAS  PubMed  Google Scholar 

  27. Dom G, Wojnar M, Crunelle CL, Thon N, Bobes J, Pruess UW, et al. Assessing and treating alcohol relapse in liver transplantation candidates. Alcohol Alcohol. 2015;50:164–72.

    Article  CAS  PubMed  Google Scholar 

  28. Lee MR, Leggio L. Management of alcohol use disorder in patients requiring liver transplant. Am J Psychiatry. 2015;172:1182–9.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Choudary NS, Kumar N, Saigal S, Rai R, Saraf N, Soin AS. Liver transplantation for alcohol related liver disease. J Clin Exp Hepatol. 2016;6:47–53.

    Article  Google Scholar 

  30. Karim Z, Intaraprasong P, Scudamore C, Erb SR, Soos JG, Cheung E, et al. Predictors of significant alcohol drinking after liver transplantation. Can J Gastroenterol. 2010;24:245–50.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Rustad JK, Stern TS, Prabhakar M, Musselman D. Risk factors for alcohol relapse following orthotopic liver transplantation: a systemic review. Psychosomatics. 2015;56:21–35.

    Article  PubMed  Google Scholar 

  32. Weinrieb RM, Van Horn DHA, Lynch KG, Lucey MR. A randomized controlled study of treatment for alcohol dependence in patients awaiting liver transplantation. Liver Transpl. 17 2011;17: 539–547.

    Article  PubMed  Google Scholar 

  33. Addolorato G, Mirijello A, Leggio L, Ferrulli A, D’Angelo C, Vassallo G, et al. Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol Clin Exp Res. 2013;37:1601–8.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Rodrigue JR, Hanto DW, Curry MP. Substance abuse treatment and its association with relapse to alcohol use after liver transplantation. Liver Transpl. 2013;19:1387–95.

    Article  PubMed  Google Scholar 

  35. Rice JP, Lucey MR. Should length of sobriety be a major determinant in liver transplant selection? Curr Opin Organ Transplant. 2013;18:259–64.

    Article  PubMed  Google Scholar 

  36. DeGottardi A, Spahr L, Golez P, Morard I, Mentha G, Guilland O. A simple score for predicting alcohol relapse after liver transplantation. Arch Int Med. 2007;167:1183–8.

    Article  Google Scholar 

  37. DiMartini AF, Dew MA, Day N, Fitzgerald MG, Jones BL, deVera M, Fontes P. Trajectories of alcohol consumption following liver transplantation. Am J Transplant. 2010;10:2305–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Beresford TP, Turcotte JG, Merion R, Burtch G, Blow FC, Campbell D, et al. A rational approach to liver transplantation for the alcoholic patient. Psychosomatics. 1990;31:241–54.

    Article  CAS  PubMed  Google Scholar 

  39. Anderson CF, personal communication.

    Google Scholar 

  40. Valliant GE. The natural history of alcoholism revisited. Cambridge: Harvard University Press; 1995.

    Google Scholar 

  41. Mathurin P, Moreno C, Samuel D, Dumortier J, Salleron J, Durand F, et al. Early liver transplantation for severe alcoholic hepatitis. NEJM. 2011;365:1790–800.

    Article  CAS  PubMed  Google Scholar 

  42. Busutill RW, DuBray BJ. Liver transplantation for alcoholic hepatitis. Ann Surg. 2017;265:30–1.

    Article  Google Scholar 

  43. Jesudian AB, Brown RS. Acute alcoholic hepatitis as indication for liver transplantation. Curr Opin Organ Transplant. 2016;21:107–10.

    Article  PubMed  Google Scholar 

  44. Artu F, Louvet A, Mathurin P. Liver transplantation for patients with alcoholic hepatitis. Liver Int. 2017;37:337–9.

    Article  Google Scholar 

  45. Im GY, Kim-Schluger L, Shenoy A, Schubert E, Goel A, Friedman SL, et al. Early liver transplantation for severe alcoholic hepatitis in the United States – a single center experience. Am J Transplant. 2016;16:841–9.

    Article  CAS  PubMed  Google Scholar 

  46. Lucey MR, Rice JP. Liver transplantation for severe alcoholic hepatitis crosses the Atlantic. Am J Transplant. 2016;16:1739–40.

    Article  Google Scholar 

  47. Schneekloth TD, Niazi SK, Simonetto DA. Alcoholic hepatitis: appropriate indication for liver transplantation? Curr Opin Organ Transplant. 2017;22:578–83.

    Article  PubMed  Google Scholar 

  48. Stroh G, Rosell T, Dong F, Forster J. Early liver transplantation for patients with acute alcoholic hepatitis: public views and the effects on organ donation. Am J Transplant. 2015;15:1598–604.

    Article  CAS  PubMed  Google Scholar 

  49. Testino L, Burra P, Bonino F, Piani F, Sumberaz A, Peressutti R, et al. Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: an Italian position statement. World J Gastroenterol. 2014;20:14642–51.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Evon DM, Burker EJ, Sedway JA, Cicale R, Davis K, Egan T. Tobacco and alcohol use in lung transplant candidates and recipients. Clin Transpl. 2005;19:207–14.

    Article  Google Scholar 

  51. Sandhu GS, Khattak M, Woodward RS, Hanto DW, Pavlakis M, Dimitri N, Goldfarb-Rumyantzev AS. Impact of substance abuse on access to renal transplantation. Transplantation. 2011;91:86–93.

    Article  PubMed  Google Scholar 

  52. Gueye AS, Chelamcharla M, Baird BC, Nguyen C, Tang H, Barenbaum AL, et al. The association between recipient alcohol dependency and long-term graft and recipient survival. Nephrol Dial Transplant. 2007;22:891–8.

    Article  PubMed  Google Scholar 

  53. Zelle DM, Agarwal PK, Ramirez JLP, van der Heide JJ, Corpeleijn E, Gans RO, Navis G, Bakker SJ. Alcohol consumption, new onset diabetes after transplantation, and all-cause mortality in renal transplant recipients. Transplantation. 2011;92:203–8.

    Article  PubMed  Google Scholar 

  54. Fierz K, Steiger J, Denhaerynck K, Dobbels F, Bock A, De Geest S. Prevalence, severity and correlates of alcohol use in adult renal transplant recipients. Clin Transpl. 2006;20:171–8.

    Article  Google Scholar 

  55. Hanrahan JS, Eberly C, Mohanty PK. Substance abuse in heart transplant recipients: a 10-year follow-up study. Prog Transplant. 2001;11:285–90.

    Article  CAS  PubMed  Google Scholar 

  56. Shapiro PA, Williams DL, Foray AT, Gelman IS, Wukich N, Sciacca R. Psychosocial evaluation and prediction of compliance problems and mortality after heart transplantation. Transplantation. 1995;60:1462–6.

    Article  CAS  PubMed  Google Scholar 

  57. Robinson M, Berke J, Gould S. Business insider- legal marijuana states 2018. January 23, 2018. http://www.businessinsider.com/legal-marijuana-states-2018-1. Accessed 1 Feb 2018.

  58. Neyer J, Uberoi A, Hamilton M, Kobashigawa JA. Marijuana and listing for heart transplant: a survey of transplant providers. Circ Heart Fail. 2016;9:1–8.

    Article  Google Scholar 

  59. Allen LA, Ambardekar AV. Hashing it out over cannabis: moving toward a standardized guideline on substance use for cardiac transplantation eligibility that includes marijuana. 2016.

    Google Scholar 

  60. Pondrom S. Transplantation and marijuana use. Am J Transplant. 2016;16:1–2.

    Article  PubMed  Google Scholar 

  61. Schwartz C. Medical marijuana patients in California are being denied organ transplants but that could change soon. 2015. http://www.huffingtonpost.com/2015/02/24/marijuana-organ-transplant_n_6736672.htm. Accessed 5 Feb 2018.

  62. Miller, K. Marijuana user who lost place on transplant list asks lawmakers to change hospital policy. 2017. https://www.pressherald.com/2017/03/27/bill-would-prohibit-hospitals-from-rejecting-organ-recipients-who-use-medical-marijuana/. Accessed 5 Feb 2018.

  63. Coffman KL. The debate about marijuana usage in transplant candidates: recent medical evidence on marijuana health effects. Curr Opin Organ Transplant. 2008;13:189–95.

    Article  PubMed  Google Scholar 

  64. Marijuana: Drug Facts. 2018. https://www.drugabuse.gov/publications/drugfacts/marijuana. Accessed 5 Feb 2018.

  65. National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press. 2017. https://doi.org/10.17226/24625.

  66. Fishman JA. Infection in solid-organ transplant recipients. NEJM. 2007;357:2601–14.

    Article  CAS  PubMed  Google Scholar 

  67. Huang JY, Zhang ZF, Tashkin DP, Feng B, Straif K, Hashibe M. An epidemiologic review of marijuana and cancer: an update. Cancer Epidemiol Biomark Prev. 2015;24:15–31.

    Article  CAS  Google Scholar 

  68. Vethanayagam D, Pugsley S, Dunn EJ, Russell D, Kay JM, Allen C. Exogenous lipid pneumonia related to smoking weed oil following cadaveric renal transplantation. Can Respir J. 2000;7:338–42.

    Article  CAS  PubMed  Google Scholar 

  69. Marks WH, Florence L, Lieberman J, Chapman P, Howard D, Roberts P, et al. Successfully treated invasive pulmonary Aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation. 1996;61:1771–4.

    Article  CAS  PubMed  Google Scholar 

  70. Hamadeh R, Ardehali A, Locksley RM, York MK. Fatal Aspergillosis associated with smoking contaminated marijuana in a bone marrow transplant recipient. Chest. 1988;94:423–33.

    Article  Google Scholar 

  71. Hauser N, Sahai T, Richards R, Roberts T. High on cannabis and calcineurin inhibitors: a word of warning in the era of legalized marijuana. Case Rep Transplant. 2016; doi:https://doi.org/10.1155/2016/4028492.

    Article  Google Scholar 

  72. Greenan G, Ahmad SB, Anders MG, Leeser A, Bromberg JS, Niederhaus SV. Recreational marijuana use is not associated with worse outcomes after renal transplantation. Clin Transpl. 2016;30:1340–6.

    Article  CAS  Google Scholar 

  73. Ranney DN, Acker WB, Al-Holou SN, Ehrlichman L, Lee DS, Lewin SA, et al. Marijuana use in potential liver transplant candidates. Am J Transplant. 2009;9:280–5.

    Article  CAS  PubMed  Google Scholar 

  74. Rai HS, Winder GS. Marijuana use and organ transplantation: a review and implications for clinical practice. Current Psychiatry Rep. 2017;19:91.

    Article  Google Scholar 

  75. Schuckit MA. Treatment of opioid use disorders. NEJM. 2016;375:357–68.

    Article  PubMed  Google Scholar 

  76. Renner JA, Knapp CM, Ciraulo DA, Epstein S. Opioids. In: Kranzler HR, Ciraulo DA, Zindel LR, editors. Clinical manual of addiction psychopharmacology. Washington, DC: American Psychiatric Publishing; 2014. p. 97–136.

    Google Scholar 

  77. Liu LU, Schiano TD, Lau N, O’Rourke M, Min AD, Sigal SH, et al. Survival and risk of recidivism in methadone dependent patients undergoing liver transplantation. Prog Transplant. 2001;11:50–7.

    Article  Google Scholar 

  78. Hancock MM, Prosser CC, Ransibrahmanakul K, Lester L, Craemer E, Bourgeois JA, Rossario L. Liver transplant and hepatitis C in methadone maintenance therapy: a case report. Subst Abuse Treat Prev Policy. 2007;2:5.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Kanchana TP, Kaul V, Manzarbeitia C, Reich DJ, Hails KC, Munoz SJ, Rothstein KD. Liver transplantation for patients on methadone maintenance. Liver Transpl. 2002;8:778–82.

    Article  PubMed  Google Scholar 

  80. Weinrieb RM, Barnett R, Lynch KG, DePiano M, Atanda A, Olthoff KM. A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone-maintained liver transplant recipients. Liver Transpl. 2004;10:97–106.

    Article  PubMed  Google Scholar 

  81. Jiao M, Greanya ED, Haque M, Yoshida EM, Soos JG. Methadone maintenance therapy in liver transplantation. Prog Transplant. 2010;20:209–14.

    Article  PubMed  Google Scholar 

  82. Aldemir E, Coskunul H, Kilic M, Sert I. Treatment of opioid dependence with buprenorphine/naloxone after liver transplantation:report of two cases. Transpl Proc. 2016;48:2769–72.

    Article  CAS  Google Scholar 

  83. Fireman M, DiMartini AF, Crone CC. Organ transplantation. In: Ferrando SJ, Levenson JL, editors. Clinical manual of psychopharmacology in the medically ill. Washington, DC: American Psychiatric Association Publishing; 2017. p. 597–631.

    Google Scholar 

  84. Dulaney DT, Dokus KM, McIntosh S, Al-Judaibi B, Ramaraju GA, Tomiyama K, et al. Tobacco use is a modifiable risk factor for post-transplant biliary complications. J Gastrointest Surg. 2017;10:1643–9.

    Article  Google Scholar 

  85. Botha P, Peaston R, White K, Forty J, Dark JH, Parry G. Smoking after cardiac transplantation. Am J Transplant. 2008;8:866–71.

    Article  CAS  PubMed  Google Scholar 

  86. Basile A, Bernazzali S, Diciolla F, Lenzini F, Lisi G, Maccherini M, et al. Risk factors for smoking abuse after heart transplantation. Transpl Proc. 2004;36:641–2.

    Article  CAS  Google Scholar 

  87. Hellemons ME, Agarwal PK, van der Bij W, Verschuuren EA, Postmus D, Erasmus ME, et al. Former smoking is a risk factor for chronic kidney disease after lung transplantation. Am J Transplant. 2011;11:2490–8.

    Article  CAS  PubMed  Google Scholar 

  88. Ruttens D, Verleden S, Vos R, Vaneylen A, Vandermeulen E, Thomeer T, et al. The impact of smoking relapse on the outcome after lung transplantation. Eur Respir J. 2012;40:S56.

    Google Scholar 

  89. Vos R, De Vusser K, Schaevers V, Schoonis A, Lemaigre V, Dobbels F, et al. Smoking resumption after lung transplantion: a sobering truth. Eur Respir J. 2010;35:1411–3.

    Article  CAS  PubMed  Google Scholar 

  90. Nourbala MH, Nemati E, Rostami Z, Einollahi B. Impact of cigarette smoking on kidney transplant recipients: a systematic review. Iran J Kidney Dis. 2011;5:141–8.

    PubMed  Google Scholar 

  91. Hurst FP, Altieri M, Patel PP, Jindal TR, Guy SR, Sidawy AN, Agodoa LY, et al. Effect of smoking on kidney transplant outcomes: analysis of the United States Renal Data System. Transplantation. 2011;92:1101–7.

    Article  CAS  PubMed  Google Scholar 

  92. DiMartini AF, Javed L, Russell S, Dew MA, Fitzgerald MG, Jain A, Fung J. Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl. 2005;11:679–83.

    Article  PubMed  Google Scholar 

  93. Mangus RS, Fridell JA, Kubal CA, Loeffler AL, Krause AA, Bell JA, et al. Worse long-term patient survival and higher cancer rates in liver transplant recipients with a history of smoking. Transplantation. 2015;99:1862–8.

    Article  PubMed  Google Scholar 

  94. Gali K, Spaderna H, Smits JM, Bramstedt KA, Weidner G. Smoking status at the time of listing for a heart transplant predicts mortality on the waiting list: a multicenter prospective observational study. Prog Transplant. 2016;26:117–21.

    Article  PubMed  Google Scholar 

  95. Li Q, Wang Y, Ma T, Liu X, Wang B, Zheng W, et al. Impact of cigarette smoking on early complications after liver transplantation: a single center experience and meta-analysis. PLoS One. 2017;12:1–15.

    Google Scholar 

  96. Mehra M, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10 year update. J Heart Lung Transplant. 2016;35:1–23.

    Article  PubMed  Google Scholar 

  97. Weill D, Benden C, Corris PA, Dark JH, Davis RD, Lederer DJ, et al. A consensus document for the selection of lung transplant candidates: 2014-an update from the pulmonary transplantation Council of the International Society for heart and lung transplantation. J Heart Lung Transplant. 2014;34:1–15.

    Article  PubMed  Google Scholar 

  98. Tsao CI, Chen RJ, Chou NK, Ko WJ, Chi NH, Yu HY, et al. The influence of donor characteristics on survival after heart transplantation. Transplant Proc. 2008;40:2636–7.

    Article  CAS  PubMed  Google Scholar 

  99. Bonser RS, Taylor R, Collett D, Thomas HL, Dark JH, Neuberger J, et al. Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry. Lancet. 2012;380:747–55.

    Article  PubMed  Google Scholar 

  100. Fruhauf NR, Fischer-Frohlich CL, Kutschmann M, Schmidtmann I, Kirste G. Joint impact of donor and recipient parameters on the outcome of liver transplantation in Germany. Transplantation. 2011;92:1378–84.

    Article  PubMed  Google Scholar 

  101. National Institute of Drug Abuse. Trends and statistics. 2017. https://www.drugabuse.gov/related-topics/trends-statistics. Accessed 9 Oct 2017.

  102. Lentine KL, Lam NN, Xiao H, Tuttle-Newhall JE, Axelrod D, Brennan DC, et al. Associations of pre-transplant prescription narcotic use with clinical complications after kidney transplantation. Am J Nephrol. 2015;41:165–76.

    Article  PubMed  Google Scholar 

  103. Randall HB, Alhamad T, Schnitzler M, Zhang Z, Ford-Glanton S, Axelrod DA, et al. Survival implications of opioid use before and after liver transplantation. Liver Transpl. 2017;23:305–14.

    Article  PubMed  Google Scholar 

  104. Donnadieu-Rigole H, Perney P, Ursic-Bedoya J, Faure S, Pageaux G. Addictive behaviors in liver transplant recipients: the real problem? World J Hepatol. 2017;9:953–8.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Tome S, Said A, Lucey MR. Addictive behavior after solid organ transplantation: what do we know already and what do we need to know? Liver Transpl. 2008;14:127–9.

    Article  PubMed  Google Scholar 

  106. Webb K, Shepherd L, Neuberger J. Illicit drug use and liver transplantation: is there a problem and what is the solution? Transpl Int. 2008;21:923–9.

    Article  PubMed  Google Scholar 

  107. Gedaly R, McHugh PP, Johnston TD, Jeon H, Koch A, Clifford TM, Ranjan D. Predictors of relapse to alcohol and illict drugs after liver transplantation for alcoholic liver disease. Transplantation. 2008;86:1090–5.

    Article  PubMed  Google Scholar 

  108. Nickels M, Jain A, Sharma R, Orloff M, Tsoulfas G, Kashyap R, Bozorgzadeh A. Polysubstance abuse in liver transplant patients and its impact on survival outcomes. Exp Clin Transplant. 2007;5:680–5.

    PubMed  Google Scholar 

  109. Department of Health and Human Resources. Ethical Principles in the Allocation of Human Organs. 2015. https://optn.transplant.hrsa.gov/resources/ethics/ethical-principles-in-the-allocation-of-human-organs/. Accessed 24 Dec 2017.

  110. American Society of Addiction Medicine. Drug Testing: A White Paper. 2013. https://www.asam.org/drug-testing-a-white-paper-by-asam.pdf. Accessed 20 Jan 2018.

  111. Piano S, Marchioro L, Gola E, Rosi S, Morando F, Cavallin M, et al. Assessment of alcohol consumption in liver transplant candidates and recipients: the best combination of tools available. Liver Transpl. 2014;20:815–22.

    Article  PubMed  Google Scholar 

  112. Carbonneau M, Jensen LA, Bain VG, Kelly K, Meeberg G, Tandon P. Alcohol use while on the liver transplant waiting list: a single center experience. Liver Transpl. 2010;16:91–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Oregon Health and Science University, Portland, OR, USA

    Marian Fireman

Authors
  1. Marian Fireman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marian Fireman .

Editor information

Editors and Affiliations

  1. Stanford University School of Medicine, Stanford, CA, USA

    Yelizaveta Sher

  2. Stanford University School of Medicine, Stanford, CA, USA

    José R. Maldonado

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Fireman, M. (2019). Substance Use Disorders in Transplant Patients. In: Sher, Y., Maldonado, J. (eds) Psychosocial Care of End-Stage Organ Disease and Transplant Patients. Springer, Cham. https://doi.org/10.1007/978-3-319-94914-7_45

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-94914-7_45

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-94913-0

  • Online ISBN: 978-3-319-94914-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation